News

Forecyte Bio and Cytiva to Collaborate on Cell and Gene Therapy Manufacturing and Development

August 31, 2022

Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.

Emerson Opens Gas Analysis Solutions Center in Scotland

August 30, 2022

Emerson’s new gas analysis solutions center, located in Cumbernauld, Scotland, intends to help plants meet sustainability goals.

Thermo Fisher Scientific Opens Viral Vector Manufacturing Site in Massachusetts

August 30, 2022

Thermo Fisher Scientific’s new 300,000 ft² facility, located in Plainville, Mass., will specialize in manufacturing viral vectors.

NIH-Funded Scientists Develop Mouse Embryo Model That Generates Neural Tubes

August 30, 2022

Scientists have developed a mouse model that could be a promising model system for research into factors affecting mammalian embryonic development and disease.

MHRA Grants Novavax COVID-19 Vaccine Expanded Conditional Marketing Authorization

August 30, 2022

Novavax’s COVID-19 vaccine, Nuvaxovid, can now be given to adolescents aged 12 to 17 in the UK.

Canvax Releases New Inorganic Pyrophosphate

August 30, 2022

Canvax’s new inorganic pyrophosphate is designed for in-vitro transcription reactions.

Revisions to Annex 1 Officially Published

August 29, 2022

The European Union publishes long-awaited changes to Annex 1.

Moderna Files Suit Against Pfizer and BioNTech

August 29, 2022

Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016.

Watson-Marlow and Franz Ziel GmbH Launch Cellefill

August 26, 2022

Watson-Marlow and Franz Ziel GmbH have launched a new integrated solution to fast-track cell, gene, and biological therapies.

ChargePoint Technology Acquires PuroVaso

August 26, 2022

ChargePoint Technology has acquired single-use container company PuroVaso.